.png){kind=icon}
.png){kind=icon}
Return
Smoking Cessation, Version 3.2022
.png){kind=icon}
OA
AI
DOI：10.6004/jnccn.2023.0013.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Although the harmful effects of smoking after a cancer diagnosis have been clearly demonstrated, many patients continue to smoke cigarettes during treatment and beyond. The NCCN Guidelines for Smoking Cessation emphasize the importance of smoking cessation in all patients with cancer and seek to establish evidence-based recommendations tailored to the unique needs and concerns of patients with cancer. The recommendations contained herein describe interven-tions for cessation of all combustible tobacco products (eg, cigarettes, cigars, hookah), including smokeless tobacco products. However, rec-ommendations are based on studies of cigarette smoking. The NCCN Smoking Cessation Panel recommends that treatment plans for all pa-tients with cancer who smoke include the following 3 tenets that should be done concurrently: (1) evidence-based motivational strategies and behavior therapy (counseling), which can be brief; (2) evidence-based pharmacotherapy; and (3) close follow-up with retreatment as needed. J Natl Compr Canc Netw 2023;21(3):297-322 doi: 10.6004/jnccn.2023.0013
Keywords:
CELL LUNG-CANCER
BRAF
Journal
J
IF:
16.4
Papers:
2.8K
Citations:
1.5W
Organization
View more organizations